Investor Relations

News Release

July 31, 2019

Chemiphar announced first quarter business summary FY2019.(248KB)

July 23, 2019

Notice regarding on-Site inspection by the Japan Fair Trade Commission (pdf, 266KB)

June 18, 2019

Chemiphar joins DeNA’s AI-powered drug discovery research collaboration (pdf, 266KB)

June 7, 2019

Chemiphar announces recurrence prevention measures and administrative action against executives, etc. taken in response to announcements from the Fair Trade Commission (pdf, 283KB)

May 20, 2019

Chemiphar announced highlights of FY2018 business results (pdf, 966KB)

May 13, 2019

Chemiphar announced business summary FY2018 (pdf, 692KB)

May 7, 2019

Revision of FY2018 forecasts (pdf, 92KB)

February 8, 2019

Chemiphar to acquire marketing authorization for oral intestinal cleansing agent PICOPREP in Japan (pdf, 148KB)

January 31, 2019

Chemiphar announced third quarter business summary FY2018. (pdf, 339KB)

January 23, 2019

Notice regarding on-Site inspection by the Japan Fair Trade Commission (pdf, 117KB)

January 16, 2019

Transfer of marketing authorization for oral intestinal cleansing agent PICOPREP® in Japan (pdf, 178KB)

December 13, 2018

Nippon Chemiphar Vietnam factory launches exports to Japan (pdf, 275KB)

November 28, 2018

Chemiphar underwrites third party allocation of shares by AI drug discovery venture MOLCURE, commence negotiations toward business alliance.(pdf, 104KB)

November 9, 2018

Chemiphar announced highlights of second quarter FY2018 business results (pdf, 417KB)

October 31, 2018

Notice of differences between forecasts and actual results for the 1st half FY2018. (pdf, 33KB)

Related Information
PageTop